The 5th Edition Drug Safety Symposium 2026

January 21–22, 2026, Dubai, United Arab Emirates — The 5th Edition Drug Safety Symposium 2026, Middle East Chapter will take place on January 21–22, 2026 at the Grand Mercure Dubai Airport Hotel in Dubai. This two-day international event will gather professionals from the pharmaceutical, biotechnology, regulatory, and healthcare sectors to discuss current trends, challenges, and advancements in drug safety and pharmacovigilance across the region.

The symposium aims to provide a practical platform for learning and collaboration, focusing on key areas such as global and regional pharmacovigilance trends, regulatory expectations, signal detection, risk management strategies, and the growing role of digital technologies, artificial intelligence, and real-world evidence in drug safety monitoring. Sessions will include keynote presentations, panel discussions, case studies, and interactive workshops designed to deliver useful and actionable insights for attendees.

The event will feature a strong lineup of expert speakers from leading pharmaceutical companies, regulatory bodies, and academic institutions. Confirmed speakers include Dr. Katya Ailabouni, Head of the National Medical Product Vigilance Section at the Emirates Drug Establishment; Dr. Ahmed Hegazy, Managing Director at PVigilant Health; Maha El Temamy, Head of the Pharmacovigilance Hub at Roche CEETRIS; Prof. Mirza R. Baig, Program Director and Professor at Dubai Medical University; and Dr. Tarik Messaoud, Medical Director of Drug Safety at ClinoSphere Inc. Additional regional and international experts will also contribute their insights on improving patient safety and strengthening pharmacovigilance systems.

The symposium is designed for professionals working in pharmacovigilance, drug safety, regulatory affairs, clinical research, medical affairs, risk management, and quality assurance. Delegates from across the Middle East, Africa, Europe, and other regions are expected to participate. With the rapid growth of the pharmaceutical industry and the increasing need for effective safety frameworks, the event provides a timely opportunity for learning, networking, and strengthening drug safety practices.

Registration is now open. Participants can view the full agenda, speaker list, and registration details on the official website at www.drugsafetysymposium.com. Early-bird and group discounts are available for both in-person and virtual attendees. The 5th Edition Drug Safety Symposium 2026 is expected to deliver a valuable and informative experience for all stakeholders committed to advancing drug safety in the Middle East and beyond.